Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression.

ACS infectious diseases - 8 Dec 2017

Wu Boyue, Ouyang Zhengyu, Lyon Christopher J, Zhang Wei, Clift Tori, Bone Christopher R, Li Boan, Zhao Zhen, Kimata Jason T, Yu Xu G, Hu Ye

Abstract excerpt

Individuals who exhibit long-term HIV suppression and CD4 T-cell preservation without antiretroviral therapy are of great interest for HIV research. There is currently no robust method for rapid identification of these "HIV controller" subjects; however, HLA-B*57 (human leukocyte antigen (major histocompatibility complex), class I, B*57) genotype exhibits modest sensitivity for this phenotype. Complement C3b and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Complement C4b

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement Factor I

Share to Genotype

Share to HIV Infections

Share to HLA-B Antigens

Source

Open in PubMed Open full text

Identifiers

PMID: 28862830
DOI: 10.1021/acsinfecdis.7b00042
PMCID: PMC5727467

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression.PMID 28862830Read ↗

Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8 + T Cell Response in HIV ControllersSemantic proximity Read ↗

HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.Semantic proximity Read ↗

Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.Semantic proximity Read ↗

HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.Semantic proximity Read ↗

HIV controllers: a multifactorial phenotype of spontaneous viral suppression.Semantic proximity Read ↗

Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.Semantic proximity Read ↗

HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.Semantic proximity Read ↗

Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV ControllersSemantic proximity Read ↗

Killer immunoglobulin-like receptor (KIR) genes are associated with the risk of episodes of high-level and detectable viremia among HIV controllersSemantic proximity Read ↗

Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.Semantic proximity Read ↗

Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.Semantic proximity Read ↗

Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.